K. Josten

Clinical phase I dose escalation and pharmacokinetic study of high-dose chemotherapy with treosulfan and autologous peripheral blood stem cell transplantation in patients with advanced malignancies.

M. E. Scheulen, Ralf A. Hilger, C. Oberhoff et al. · PubMed · 2000 · 110 citations

Pharmacy, Oncology, Pharmacokinetics +16

High-risk additional chromosomal abnormalities at low blast counts herald death by CML

Rüdiger Hehlmann, Astghik Voskanyan, Michael Lauseker et al. · Leukemia · 2020 · 92 citations · Full text

Life Sciences, Hematology, Oncology +16

Talactoferrin alfa versus placebo in patients with refractory advanced non-small-cell lung cancer (FORTIS-M trial)

Suresh S. Ramalingam, Jeffrey Crawford, Alex Y. Chang et al. · Annals of Oncology · 2013 · 56 citations · Full text

Medicine, Oncology, Pharmacology +9

Successful Treatment of Catastrophic Antiphospholipid Antibody Syndrome (CAPS) Associated With Splenic Marginal-zone Lymphoma With Low-molecular Weight Heparin, Rituximab and Bendamustine

Hendrik Manner, Nicola Plum, Bernd Jung et al. · The American Journal of the Medical Sciences · 2008 · 30 citations

Medicine, Hematology, Immunology +10

Cyclic alternating chemotherapy of high-grade malignant non-Hodgkin lymphomas with VIM-Bleo and CHOP

B. Steinke, K. Bross, H.-M. Reinold et al. · European Journal of Cancer · 1992 · 10 citations

Medicine, Oncology, Chemotherapy +11